Clinical Trial Update: Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing azilsartan medoxomil to ramipril for essential hypertension evaluated efficacy and safety; the study results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Azilsartan medoxomil (azilsartan medoxomil)
• Ramipril (ramipril)

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-04-19